Jessica Taylor

Cooley secured a summary judgment with prejudice for Aurinia Pharmaceuticals (Aurinia), a Canada-based company focused on developing therapies to treat autoimmune diseases, in a securities class action challenging numerous public statements made over a period of nine months. The Cooley team was led by securities litigation and enforcement partners Koji Fukumura and Ryan Blair, with support from associates Heather Speers, Matt Martinez and Jessica Taylor. The case is Michael J. Ortmann v. Aurinia Pharmaceuticals, Inc. et al. (Case No.: 22-1335-BAH).

Cooley secured another win on behalf of IonQ, a quantum computing hardware and software company, when a district court issued an order denying the plaintiffs’ attempt to amend their complaint and request that the court reconsider its prior dismissal with prejudice of a consolidated securities fraud class action.

Cooley represented IonQ, a quantum computing hardware and software company, in a consolidated securities fraud class action initially brought by former investor Michael Leacock.